Evidence of Subsequent Remedial Measures: Strategies and Practical Considerations Under FRE 407
Recording of a 90-minute CLE video webinar with Q&A
This CLE webinar will discuss strategies to position counsel either to put evidence of remedial measures in front of a jury or to make sure it is excluded. The program will review Federal Rule of Evidence 407 and its many exceptions, the relevancy requirement of FRE 403, and how defendants' instinct to disclaim responsibility and plaintiffs' instinct to secure admissions affects admissibility of this powerful category of evidence. The panel will also discuss the ongoing debates: (1) whether FRE 407 applies to every change that would have made the plaintiff's injury less likely to occur or only those made in response to the injury, and (2) whether the rule applies beyond injury cases, such as in contract actions.
Outline
- Evolution of FRE 407 and policy rationales
- Analysis of the rule
- Defining subsequent remedial measure
- Application to contract actions
- Causation requirement
- Impermissible uses
- Exceptions
- Defining subsequent remedial measure
- Strategies for getting subsequent remedial conduct into evidence
- Strategies for excluding subsequent remedial conduct
Benefits
The panel will review these and other important issues:
- Does Rule 407 apply to every change that would have made the injury less likely to occur or just those made in response to the injury?
- Does Rule 407 apply to contracts, such as new insurance exclusions?
- Does Rule 407 apply to contributory negligence issues?
- Is it ever beneficial to affirmatively introduce remedial measures?
- How can subsequent remedial measures be used for impeachment?
- Are communications that refer to subsequent remedial measures excludable?
Faculty
Ashleigh L. Angeletti
Attorney
DLA Piper
Ms. Angeletti focuses her practice on the defense of medical device, life science, and pharmaceutical companies in a... | Read More
Ms. Angeletti focuses her practice on the defense of medical device, life science, and pharmaceutical companies in a variety of cases, including coordinated and multidistrict product liability litigation, complex commercial litigation, and investigations. In addition, her practice includes litigating consumer class actions and counseling clients in business disputes.
CloseChristopher G. Campbell
Partner
DLA Piper
Mr. Campbell is a partner in the firm’s Product Liability and Mass Tort practice. He has experience in all phases... | Read More
Mr. Campbell is a partner in the firm’s Product Liability and Mass Tort practice. He has experience in all phases of litigation, including first-chairing jury and bench trials in state and federal courts and arguing appeals. He is co-author of the book Expert Witnesses: Products Liability Cases (West 2009), an in-depth guide to expert witness development in all types of product liability and mass tort matters, including pharmaceutical, toxic torts, automotive, industrial accidents and children's and consumer products.
Close